Recovery of OCT findings after the treatment of AMD Recovery of photoreceptor outer segments after anti-VEGF therapy for age-related macular degeneration

[1]  Y. Kurimoto,et al.  Restoration of the photoreceptor outer segment and visual outcomes after macular hole closure: spectral-domain optical coherence tomography analysis , 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.

[2]  M. Mandai,et al.  Remission and Dropout Rate of Anti-VEGF Therapy for Age-Related Macular Degeneration , 2011, European journal of ophthalmology.

[3]  Christian Ahlers,et al.  Quantification of the therapeutic response of intraretinal, subretinal, and subpigment epithelial compartments in exudative AMD during anti-VEGF therapy. , 2011, Investigative ophthalmology & visual science.

[4]  H. Koh,et al.  Predictors of response after intravitreal bevacizumab injection for neovascular age-related macular degeneration , 2010, Japanese Journal of Ophthalmology.

[5]  C. Sung,et al.  The cell biology of vision , 2010, The Journal of cell biology.

[6]  Masayuki Hata,et al.  The significance of external limiting membrane status for visual acuity in age-related macular degeneration. , 2010, American journal of ophthalmology.

[7]  Richard B Rosen,et al.  INNER SEGMENT–OUTER SEGMENT JUNCTIONAL LAYER INTEGRITY AND CORRESPONDING RETINAL SENSITIVITY IN DRY AND WET FORMS OF AGE-RELATED MACULAR DEGENERATION , 2010, Retina.

[8]  I. Moroz,et al.  Optical coherence tomography predictors of retinal pigment epithelial tear following intravitreal bevacizumab injection. , 2009, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[9]  N. Bressler.  Antiangiogenic approaches to age-related macular degeneration today. , 2009, Ophthalmology.

[10]  A. Tsujikawa,et al.  Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. , 2009, American journal of ophthalmology.

[11]  R. P. Singh,et al.  Predictive factors of visual and anatomical outcome after intravitreal bevacizumab treatment of neovascular age-related macular degeneration: an optical coherence tomography study , 2009, British Journal of Ophthalmology.

[12]  P. Presti,et al.  Relationships between clinical measures of visual function and anatomic changes associated with bevacizumab treatment for choroidal neovascularization in age-related macular degeneration , 2009, Eye.

[13]  A. Pollack,et al.  Early OCT changes of neuroretinal foveal thickness after first versus repeated PDT in AMD , 2009, International Ophthalmology.

[14]  P. Keane,et al.  Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. , 2008, Ophthalmology.

[15]  D. Sarraf,et al.  PREDICTORS OF Anti-VEGF-ASSOCIATED RETINAL PIGMENT EPITHELIAL TEAR USING FA AND OCT ANALYSIS , 2008, Retina.

[16]  C. Regillo,et al.  Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. , 2007, American journal of ophthalmology.

[17]  K. Eng,et al.  Ranibizumab in neovascular age-related macular degeneration , 2006, Clinical interventions in aging.

[18]  Susan Schneider,et al.  Ranibizumab versus verteporfin for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.

[19]  Wolfgang Drexler,et al.  Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology. , 2005, Ophthalmology.

[20]  J. Fujimoto,et al.  Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. , 2003, Archives of ophthalmology.

[21]  J. Duker,et al.  Macular disease and optical coherence tomography. , 1996, Current Opinion in Ophthalmology.

[22]  Javier Zarranz-Ventura,et al.  Optical Coherence Tomography in Age-related Macular Degeneration Authors: , 2018 .

[23]  Mark Michels,et al.  Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. , 2009, Ophthalmology.

[24]  G. Coscas,et al.  Clinical Features and Natural History of AMD , 2009 .